Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Leonard Schleifer
Age : 68
Public asset : 1,527,987,269 USD
Country of residence : Unknown
Linked companies : Regeneron Pharmaceuticals, Inc.

Biography of Leonard Schleifer 
Founder of Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer is Co-President, Chief Executive Officer & Director at this company. He previously was Assistant Professor at Weill Cornell Medical College. Dr. Schleifer received a doctorate from the University of Virginia.


Current positions of Leonard Schleifer 
Holdings of Leonard Schleifer 
Leonard Schleifer : Personal Network 
Most Read News 
01/18ELON MUSK : Tesla investors urge judge to order Musk repay $13 billion for SolarCity deal
RE
01/11JAMIE DIMON : JPMorgan's Dimon says consumer loan growth may take 6-9 months to return to normal
RE
01/13JACK DORSEY : Jack Dorsey's Block to build an open bitcoin mining system
RE
01/14ELON MUSK : Musk says Tesla to accept dogecoin for merchandise
RE
01/20ALAN JOPE : Unilever strategy under scrutiny after short-lived GSK skirmish
RE
01/10BRUNELLO CUCINELLI : Luxury group Cucinelli posts 31% sales jump in 2021
RE
01/11CATHIE WOOD : ARK's Wood turns focus to deflation, 'stay connected' stocks
RE
01/12MARTIN SORRELL : Sorrell's S4 says trading well ahead of guidance
RE
01/13AMANCIO ORTEGA : Inditex founder Amancio Ortega buys Toronto's Royal Bank Plaza for $916 mln
RE
01/17ELON MUSK : Top Energy News of the Day
DJ
More news


© 2022 People and Ownership :   
Leonard Schleifer : Connections 


Latest news about Leonard Schleifer 
2021Regeneron beats quarterly sales on COVID-19 drug demand
RE
2021Regeneron beats quarterly sales on COVID-19 drug demand
RE
2021REGENERON PHARMACEUTICALS : U.S. to buy 1.4 mln additional doses of Regeneron's COVID-19 therapy
RE
2021REGENERON PHARMACEUTICALS : sees uptick in COVID-19 therapy use as cases rise
RE
2021From Tesla to GE, See How Much CEOs Made in 2020
DJ
2021Regeneron expects continuing demand for its COVID-19 therapy
RE
2021Buffett Stands Alone, but Companies Should Open Door to Older CEOs
DJ
More news